21 related articles for article (PubMed ID: 37173019)
1. Comparison of anti-allergic activities of different types of lotus seed resistant starch in OVA-induced mouse model.
Lin Z; Wang Y; Li L; Zheng B; Hu J; Zhang Y
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132389. PubMed ID: 38754655
[TBL] [Abstract][Full Text] [Related]
2. Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial.
Miao T; Zhang X; Zhang C; Wu J; Zhu Y; Xiao M; Zhang N; Zhong Y; Liu Y; Lin Y; Wu Y; Li W; Song C; Liu Y; Wang X
Pharmacol Res; 2024 Jul; 205():107232. PubMed ID: 38825157
[TBL] [Abstract][Full Text] [Related]
3. Lotus seed resistant starch ameliorates high-fat diet induced hyperlipidemia by fatty acid degradation and glycerolipid metabolism pathways in mouse liver.
He S; Xiong Z; Li L; Wang Y; Wang C; Zheng B; Zeng H; Zhang Y
Int J Biol Macromol; 2022 Aug; 215():79-91. PubMed ID: 35718147
[TBL] [Abstract][Full Text] [Related]
4. Effect of lotus seed resistant starch on small intestinal flora and bile acids in hyperlipidemic rats.
Lei S; He S; Li X; Zheng B; Zhang Y; Zeng H
Food Chem; 2023 Mar; 404(Pt A):134599. PubMed ID: 36444019
[TBL] [Abstract][Full Text] [Related]
5. Effect of lotus seed resistant starch on the bioconversion pathway of taurocholic acid by regulating the intestinal microbiota.
He S; Li L; Lei S; Su J; Zhang Y; Zeng H
Int J Biol Macromol; 2024 May; 266(Pt 1):131174. PubMed ID: 38552699
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of lotus seed resistant starch and short-chain fatty acids on mice fecal microbiota in vitro.
Li X; Lei S; Liu L; Zhang Y; Zheng B; Zeng H
Int J Biol Macromol; 2021 Jul; 183():2272-2281. PubMed ID: 34097970
[TBL] [Abstract][Full Text] [Related]
7. Effect of lotus seed resistant starch on tolerance of mice fecal microbiota to bile salt.
Lei S; Li X; Liu L; Zheng M; Chang Q; Zhang Y; Zeng H
Int J Biol Macromol; 2020 May; 151():384-393. PubMed ID: 32084485
[TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review.
Birkeland E; Gharagozlian S; Valeur J; Aas AM
Lipids Health Dis; 2023 Mar; 22(1):40. PubMed ID: 36915164
[TBL] [Abstract][Full Text] [Related]
9. Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia.
Jia X; Xu W; Zhang L; Li X; Wang R; Wu S
Front Cell Infect Microbiol; 2021; 11():634780. PubMed ID: 34490132
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-metabolic axis insight into the hyperlipidemic effect of lotus seed resistant starch in hyperlipidemic mice.
Zeng H; He S; Xiong Z; Su J; Wang Y; Zheng B; Zhang Y
Carbohydr Polym; 2023 Aug; 314():120939. PubMed ID: 37173019
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
